Nephrocare Health Services rises as its arm incorporates wholly-owned subsidiary in Kazakhstan
Nephrocare Health Services is currently trading at Rs. 613.00, up by 6.10 points or 1.01% from its previous closing of Rs. 606.90 on the BSE.
The scrip opened at Rs. 609.00 and has touched a high and low of Rs. 618.20 and Rs. 606.00 respectively. So far 2427 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 661.75 on 18-May-2026 and a 52 week low of Rs. 445.00 on 19-Dec-2025.
Last one week high and low of the scrip stood at Rs. 661.75 and Rs. 522.00 respectively. The current market cap of the company is Rs. 6122.79 crore.
The promoters holding in the company stood at 63.85%, while Institutions and Non-Institutions held 18.59% and 17.56% respectively.
Nephrocare Health Services’ overseas wholly-owned subsidiary -- Nephrocare Health Services International (NHSI), Singapore, has incorporated a new overseas wholly-owned subsidiary in Kazakhstan under the name and style of Nephroplus Health Services Kazakhstan Liability Partnership (LLP) (NPHSK LLP) on May 26, 2026, in accordance with the applicable laws of Kazakhstan. Consequent to the aforesaid incorporation, NPHSK LLP has become a step-down overseas wholly-owned subsidiary of the Company.
NPHSK LLP has been incorporated with the objective of undertaking holding and management activities to expand its kidney care and dialysis services network in Kazakhstan. In furtherance of this objective, NPHSK LLP shall engage in all activities that are incidental or ancillary thereto, including, but not limited to, the establishment and operation of dialysis centres, procurement of medical equipment and consumables, and the provision of comprehensive patient care and related healthcare services.
